# Living Optics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/living-optics

- Industry: Hardware
- Headquarters: Abingdon, UK
- Website: www.livingoptics.com/
- Total disclosed funding: $28M
- Latest round: Series A (Aug 12, 2022)
- Investors on record: 4

## About

Living Optics develops cutting-edge hyperspectral imaging technologies aimed at enhancing analytical capabilities across various sectors, including agriculture, healthcare, and security. Founded in 2020, Living Optics is headquartered in Oxford, UK, specializing in hyperspectral imaging solutions. In October 2026, Living Optics Limited raised USD 20 million in venture funding led by BRV Capital Management, with participation from Lockheed Martin Ventures, Applied Ventures, Lam Capital, GK Goh Ventures, British Business Bank, OTIF Ventures, Octopus Ventures and Foresight Group. Robin W. serves as both the Founder and CEO, guiding its strategic vision and operations. Living Optics primarily develops and offers advanced hyperspectral imaging technologies designed for various applications across multiple sectors. Their flagship product is the Living Optics Camera, which provides video-rate hyperspectral imaging capabilities that are both affordable and user-friendly. By integrating hyperspectral imaging into practical applications, the company aims to enhance decision-making in sectors such as agriculture, healthcare, and security. For instance, in agriculture, their technology allows farmers to assess crop growth and environmental impacts such as soil quality. In healthcare, it helps distinguish between different tissue types, improving diagnostic accuracy. The company serves a diverse client base that includes agricultural professionals, healthcare institutions, and security agencies, catering to markets primarily in North America, Europe, and parts of Asia. Living Optics generates revenue through the direct sale of its hyperspectral imaging cameras and associated technologies, forming partnerships with various sectors to support product deployment and integration. The business model involves direct sales to institutional clients such as hospitals and agricultural firms, as well as partnerships with distributors who facilitate broader market access. Revenue transactions typically occur through single purchases of imaging systems, accompanied by potential service agreements for ongoing support and maintenance. The company's strategic focus on making hyperspectral imaging accessible is reflected in its pricing structure, which is tailored to attract clients across different market segments, including large-scale agriculture and healthcare diagnostics. Their commitment to innovative solutions positions them favorably within their target markets, enhancing overall revenue potential.

The company will use the October 2026 funding to drive global platform adoption across target industries and markets.

## Funding rounds

- Series A, Aug 12, 2022, $24M — Foresight Group, Oxford Sciences Enterprises, Octopus Investments, Braavos Investment Advisers
- Seed, Feb 27, 2020, $4.2M — Foresight Group, Oxford Sciences Enterprises

## Investors

- Foresight Group (https://capitalatlas.ai/funds/foresight-group) — Seed, Series A
- Oxford Sciences Enterprises (https://capitalatlas.ai/funds/oxford-sciences-enterprises) — Seed, Series A
- Octopus Investments (https://capitalatlas.ai/funds/octopus-investments) — Series A
- Braavos Investment Advisers (https://capitalatlas.ai/funds/braavos-investment-advisers) — Series A